home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

How Harmonized Scientific Data in the Cloud Will Fuel the Next Evolution of Drug Discovery

 
  February 03, 2022  
     
 


xtalks.com, webinar
Friday, February 25, 2022 | 11am EST (NA)


Who Should Attend?

This webinar is a must-watch event for life sciences R&D IT teams, lab scientists and data scientists that are faced with the daunting task of navigating the chaotic data ecosystem. Professional roles include but are not limited to:

  • R&D IT Developers
  • Project Managers
  • Data Architects/Engineers
  • Bench Scientists
  • Data Scientists

What You Will Learn

In this webinar, attendees will learn how life science organizations can shift focus to higher-value and more productive work, improve outcomes and speed innovative discoveries with scientific data that are:

  • Compliant
  • Harmonized
  • Liquid
  • Actionable
 
 
Organized by: xtalks.com
Invited Speakers:

Speaker

http://Ken%20Fountain,%20TetraScience

Ken Fountain, Field Scientist, TetraScience

Ken is currently a Lead Scientific Business Analyst at Tetrascience, where he develops use cases to help pharmaceutical and biotechnology companies replatform their R&D data to the cloud.  Ken began his career as a chemist at Waters Corporation in 2001, where he developed analytical methods for oligonucleotide, peptide, and protein analysis. In 2004, he moved to Genzyme Corporation (now Sanofi Genzyme), where he implemented UPLC for the analysis of small molecules. Ken returned to Waters in 2007, where he managed the Chemistry Applied Technology and Technology Advancement groups, both of which focused on development and application of consumables for the pharmaceutical, biopharmaceutical, and food and environmental markets. Ken also served as Director of the Biopharmaceutical Business, Senior Director of Scientific Operations, and Senior Director of Global Products responsible for new LC technology development at Waters.  Before joining Tetrascience, Ken was a Senior Research Fellow at Vertex Pharmaceuticals in Boston, Massachusetts, where he led all analytical development activities for the next generation cystic fibrosis potentiator (VX-561), as well as all analytical HPLC method development efforts for small molecule drug assets in the acute and chronic pain disease area.  Ken received his B.S. in Biotechnology from the Worcester Polytechnic Institute (Worcester, MA) and his M.S. in Chemistry from Tufts University (Medford, MA).

 
Deadline for Abstracts: na
 
Registration: https://xtalks.com/webinars/how-harmonized-scientific-data-in-the-cloud-will-fuel-the-next-evolution-of-drug-discovery/
E-mail: shunte@xtalks.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.